Skip to main content
Clinical Trials/CTRI/2023/12/060887
CTRI/2023/12/060887
Not yet recruiting
未知

To evaluate the in vivo safety and efficacy of a skin care formulations in terms of Skin Brightening, Skin Tone Evenness, and reduction in Acne PIH on healthy human subjects - NI

Satiya Nutraceuticals Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Satiya Nutraceuticals Private Limited
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Satiya Nutraceuticals Private Limited

Eligibility Criteria

Inclusion Criteria

  • 1\.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar)
  • 2\.Having normal skin type with Dark Spots (Acne PIH) at least 1 spot.
  • 3\.Having uneven skin tone.
  • 4\.Having dull skin.

Exclusion Criteria

  • 1\)For female: Being pregnant or breastfeeding or having stopped to
  • breastfeed in the past three months.
  • 2\)Having refused to give her
  • assent by signing the consent form.
  • 3\)Taking part in another study liable to interfere with this study.
  • 4\)Being insulin\-dependent diabetic or non insulin\-dependent diabetic
  • with a recent therapy (less than 6 months)
  • 5\)Having a progressive asthma (either under treatment or last fit in
  • the last 2 years)
  • 6\)Being epileptic

Outcomes

Primary Outcomes

Not specified

Similar Trials